At last, together with delayed from Monday...RxPG News reports that NGO Medicin sans Frontiers has expressed concern at India’s recent amendments to its Patent Act. Previous Republic of Republic of India did non grant production patents, only this has changed inwards an displace to brand Republic of Republic of India TRIPs compliant. This volition larn far easier for pharmaceutical companies to obtain Indian patents. Republic of Republic of India has likewise made it harder to larn compulsory licences granted on populace wellness grounds. However, patented technology that is already the plain of study of a compulsory licence volition proceed to live available to the manufacturers of generics, only on payment of a licence fee. Currently 50% of those on anti-retroviral drugs rely on Indian generic versions.
thinks that, if there’s a problem, the right mode isn’t to laid on Republic of Republic of India for complying amongst its international obligations. Either it’s to telephone vociferation upward for TRIPs to live amended to improve stimulate got into concern human relationship the needs of those who cannot afford crucial treatment, or to proceed to encourage the IP rights-holders to brand those drugs available to those inwards serious demand on preferential terms.
Tidak ada komentar:
Posting Komentar